India's Generic GLP-1 Boom Hits Ozempic as Brain Benefits Emerge

The Story

Picture this: you're battling the bulge and the blues, and one class of drugs might tackle both. That's the buzz around GLP-1 agonists like Ozempic and Wegovy. In the last day, two massive developments hit: Indian drugmakers are unleashing dirt-cheap generic versions of semaglutide, Novo's blockbuster, flooding the market and slashing prices. Meanwhile, fresh research from Healthline spotlights how these meds could ease anxiety and depression, opening a whole new frontier beyond...